# Takeda

CD19-CAR-NK (with MD Anderson) — cord-blood, phase II lymphoma.

Source: https://en.bioecon.ru/companies/takeda/
Updated: 2026-06-24

- Country: Japan

## Technologies

- [Enzymatic therapy for celiac](https://en.bioecon.ru/technology/enzymatic-therapy-celiac/)
- [NK-cell & CAR-NK therapy](https://en.bioecon.ru/technology/nk-cell-car-nk-therapy/)